XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover Page - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Feb. 15, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-35986    
Entity Registrant Name Esperion Therapeutics, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 26-1870780    
Entity Address, Address Line One 3891 Ranchero Drive, Suite 150    
Entity Address, City or Town Ann Arbor    
Entity Address, State or Province MI    
Entity Address, Postal Zip Code 48108    
City Area Code 734    
Local Phone Number 887-3903    
Title of 12(b) Security Common Stock, $0.001 par value    
Trading Symbol ESPR    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 142.5
Entity Common Stock, Shares Outstanding   185,052,705  
Documents Incorporated by Reference
Part III of this Annual Report on Form 10-K incorporates by reference information from the definitive Proxy Statement for the registrant’s 2024 Annual Meeting of Shareholders, which is expected to be filed with the Securities and Exchange Commission not later than 120 days after the Registrant’s fiscal year ended December 31, 2023.
    
Entity Central Index Key 0001434868    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false